Functional, genetic, and epigenetic aspects of base and nucleotide excision repair in colorectal carcinomas

Clinical Cancer Research

Volumn 18, Issue 21, 2012, Pages 5878-5887

  Slyskova, Jana ^a,c   Korenkova, Vlasta ^b   Collins, Andrew R ^d   Prochazka, Pavel ^a,c   Vodickova, Ludmila ^a,c,e   Svec, Jiri ^a,c   Lipska, Ludmila ^f   Levy, Miroslav ^f   Schneiderova, Michaela ^g   Liska, Vaclav ^c   Holubec, Lubos ^c   Kumar, Rajiv ^h   Soucek, Pavel ^e   Naccarati, Alessio ^a,i   Vodicka, Pavel ^a,c  

^a INSTITUTE OF MATHEMATICS   (Czech Republic)

^b INSTITUTE OF BIOTECHNOLOGY   (Czech Republic)

^c CHARLES UNIVERSITY   (Czech Republic)

^d UNIVERSITY OF OSLO   (Norway)

^e NATIONAL INSTITUTE OF PUBLIC HEALTH   (Czech Republic)

^f FAKULTNÍ THOMAYEROVA NEMOCNICE   (Czech Republic)

^g CHARLES UNIVERSITY   (Czech Republic)

^h GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

ⁱ Human Genetics Foundation   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN H; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; XERODERMA PIGMENTOSUM GROUP A PROTEIN; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

AGED; APEX1 GENE; ARTICLE; BLOOD CELL; CARCINOGENESIS; CCNH GENE; COLON BIOPSY; COLORECTAL CARCINOMA; COMET ASSAY; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; CSB GENE; DNA REPAIR; DNA REPAIR CAPACITY; EPIGENETICS; EXCISION REPAIR; FEASIBILITY STUDY; FEMALE; FUNCTIONAL GENOMICS; GENE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; GENETIC COMPLEMENTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METHYLATION; MUCOSA; NEIL1 GENE; OGG1 GENE; PARP1 GENE; PRIORITY JOURNAL; PROMOTER REGION; XPA GENE; XPD GENE;

AGED; CARCINOMA; COLORECTAL NEOPLASMS; CPG ISLANDS; DNA METHYLATION; DNA REPAIR; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROMOTER REGIONS, GENETIC;

EID: 84868581612     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-12-1380     Document Type: Article

References (49)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008:GLOBOCAN2008. Int J Cancer 2008;127:2893-917.
2. George B, Kopetz S. Predictive and prognostic markers in colorectal cancer. Curr Oncol Rep 2011;13:206-15.
3. Walther A, Johnstone E, Swanton C, Midgley R, Tomlinson I, Kerr D. Genetic prognostic and predictive markers in colorectal cancer. Nat Rev Cancer 2009;9:489-99.
4. Lord CJ, Ashworth A. The DNA damage response and cancer therapy. Nature 2012;481:287-94.
5. Markowitz SD, Bertagnolli MM. Molecular origins of cancer: molecular basis of colorectal cancer. N Engl J Med 2009;361:2449-60.
6. Potter JD. Colorectal cancer: molecules and populations. J Natl Cancer Inst 1999;91:916-32. (Pubitemid 29272518)
7. Roberton AM. Roles of endogenous substances and bacteria in colorectal cancer. Mutat Res 1993;290:71-8. (Pubitemid 23319758)
8. Kinouchi T, Kataoka K, Miyanishi K, Akimoto S, Ohnishi Y. Biological activities of the intestinal microflora in mice treated with antibiotics or untreated and the effects of the microflora on absorption and metabolic activation of orally administered glutathione conjugates of Kregion epoxides of 1-nitropyrene. Carcinogenesis 1993;14:869-74. (Pubitemid 23169139)
9. Massaad L, de Waziers I, Ribrag V, Janot F, Beaune PH, Morizet J, et al. Comparison of mouse and human colon tumors with regard to phase I and phase II drug-metabolizing enzyme systems. Cancer Res 1992;52:6567-75.
10. Itzkowitz SH, Yio X. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol 2004;287:G7-17.
11. Wyatt MD, WilsonDMIII. Participation of DNA repair in the response to 5-fluorouracil. Cell Mol Life Sci 2009;66:788-99.
12. Martin LP, Hamilton TC, Schilder RJ. Platinum resistance: the role of DNA repair pathways. Clin Cancer Res 2008;14:1291-5. (Pubitemid 351413906)
13. Naccarati A, Pardini B, Hemminki K, Vodicka P. Sporadic colorectal cancer and individual susceptibility: a review of the association studies investigating the role of DNA repair genetic polymorphisms. Mutat Res 2007;635:118-45. (Pubitemid 46756400)
14. Tomlinson IP, Houlston RS, Montgomery GW, Sieber OM, Dunlop MG. Investigation of the effects of DNA repair gene polymorphisms on the risk of colorectal cancer. Mutagenesis 2012;27:219-23.
15. Lahtz C, Pfeifer GP. Epigenetic changes ofDNArepair genes in cancer. J Mol Cell Biol 2011;3:51-8.
16. Yu J, Mallon MA, Zhang W, Freimuth RR, Marsh S, Watson MA, et al. DNA repair pathway profiling and microsatellite instability in colorectal cancer. Clin Cancer Res 2006;12:5104-11. (Pubitemid 44453337)
17. Paz-Elizur T, Sevilya Z, Leitner-Dagan Y, Elinger D, Roisman LC, Livneh Z. DNA repair of oxidative DNA damage in human carcinogenesis: potential application for cancer risk assessment and prevention. Cancer Lett 2008;266:60-72.
18. Collins AR, Gaivao I. DNA base excision repair as a biomarker in molecular epidemiology studies. Mol Aspects Med 2007;28:307-22. (Pubitemid 47331612)
19. Slyskova J, Naccarati A, Pardini B, Polakova V, Vodickova L, Smerhovsky Z, et al. Differences in nucleotide excision repair capacity between newly diagnosed colorectal cancer patients and healthy controls. Mutagenesis 2012;27:225-32.
20. Langie SA, Cameron KM, Waldron KJ, Fletcher KP, von Zglinicki T, Mathers JC. Measuring DNA repair incision activity of mouse tissue extracts towards singlet oxygen-induced DNA damage: a comet-based in vitro repair assay. Mutagenesis 2011;26:461-71.
21. Langie SA, Kowalczyk P, Tudek B, Zabielski R, Dziaman T, Olinski R, et al. The effect of oxidative stress on nucleotide-excision repair in colon tissue of newborn piglets. Mutat Res 2010;695:75-80.
22. Shaposhnikov S, Azqueta A, Henriksson S, Meier S, Gaivao I, Huskisson NH, et al. Twelve-gel slide format optimised for comet assay and fluorescent in situ hybridisation. Toxicol Lett 2010;195:31-4.
23. Olive PL, Banath JP. The comet assay: a method to measure DNA damage in individual cells. Nat Protoc 2006;1:23-9.
24. Human DNA Repair Genes. Available from: http://sciencepark.mdanderson. org/labs/wood/DNA-Repair-Genes.html#NER.
25. Spurgeon SL, Jones RC, Ramakrishnan R. High throughput gene expression measurement with real time PCR in a microfluidic dynamic array. PLoS ONE 2008;3:e1662.
26. CpG Island Searcher. Available from: http://cpgislands.usc.edu/.
27. Li LC, Dahiya R. MethPrimer: designing primers for methylation PCRs. Bioinformatics 2002;18:1427-31. (Pubitemid 35414532)
28. Guan H, Ji M, Hou P, Liu Z, Wang C, Shan Z, et al. Hypermethylation of the DNA mismatch repair gene hMLH1 and its association with lymph node metastasis and T1799A BRAF mutation in patients with papillary thyroid cancer. Cancer 2008;113:247-55.
29. Reed E. Nucleotide excision repair and anti-cancer chemotherapy. Cytotechnology 1998;27:187-201. (Pubitemid 29025469)
30. Collins AR, Azqueta A. DNA repair as a biomarker in human biomonitoring studies; further applications of the comet assay. Mutat Res 2012;736:122-9.
31. Herrera M, Dominguez G, Garcia JM, Pena C, Jimenez C, Silva J, et al. Differences in repair of DNA cross-links between lymphocytes and epithelial tumor cells from colon cancer patients measured in vitro with the comet assay. Clin Cancer Res 2009;15:5466-72.
32. Jonsson C, Stal P, Sjoqvist U, Akerlund JE, Lofberg R, Moller L. DNA adducts in normal colonic mucosa from healthy controls and patients with colon polyps and colorectal carcinomas. Mutagenesis 2010;25:499-504.
33. Kirkali G, Keles D, Canda AE, Terzi C, Reddy PT, Jaruga P, et al. Evidence for upregulated repair of oxidatively induced DNA damage in human colorectal cancer. DNA Repair (Amst) 2011;10:1114-20.
34. Pfohl-Leszkowicz A, Grosse Y, Carriere V, Cugnenc PH, Berger A, Carnot F, et al. High levels of DNA adducts in human colon are associated with colorectal cancer. Cancer Res 1995;55:5611-6.
35. Sarasin A, Kauffmann A. Overexpression of DNA repair genes is associated with metastasis: a new hypothesis. Mutat Res 2008;659:49-55.
36. D'Errico M, Parlanti E, Teson M, de Jesus BM, Degan P, Calcagnile A, et al. New functions of XPC in the protection of human skin cells from oxidative damage. EMBO J 2006;25:4305-15. (Pubitemid 44435228)
37. Osterod M, Larsen E, Le Page F, Hengstler JG, Van Der Horst GT, Boiteux S, et al. A global DNA repair mechanism involving the Cockayne syndrome B (CSB) gene product can prevent the in vivo accumulation of endogenous oxidative DNA base damage. Oncogene 2002;21:8232-9. (Pubitemid 35477863)
38. Nouspikel T, Hanawalt PC. DNA repair in terminally differentiated cells. DNA Repair (Amst) 2002;1:59-75. (Pubitemid 34475693)
39. Hyka-Nouspikel N, Lemonidis K, Lu WT, Nouspikel T. Circulating human B lymphocytes are deficient in nucleotide excision repair and accumulate mutations upon proliferation. Blood 2011;117:6277-86.
40. Cheng L, Guan Y, Li L, Legerski RJ, Einspahr J, Bangert J, et al. Expression in normal human tissues of five nucleotide excision repair genes measured simultaneously by multiplex reverse transcription-polymerase chain reaction. Cancer Epidemiol Biomarkers Prev 1999;8:801-7. (Pubitemid 29445017)
41. Brooks JD. Translational genomics: the challenge of developing cancer biomarkers. Genome Res 2012;22:183-7.
42. Stevens EV, Nishizuka S, Antony S, Reimers M, Varma S, Young L, et al.Predicting cisplatin and trabectedin drug sensitivity in ovarian and colon cancers. Mol Cancer Ther 2008;7:10-8.
43. Damia G, Guidi G, D'Incalci M. Expression of genes involved in nucleotide excision repair and sensitivity to cisplatin and melphalan in human cancer cell lines. Eur J Cancer 1998;34:1783-8. (Pubitemid 28474236)
44. Vogel U, Dybdahl M, Frentz G, Nexo BA. DNA repair capacity: inconsistency between effect of over-expression of five NER genes and the correlation to mRNA levels in primary lymphocytes. Mutat Res 2000;461:197-210.
45. Hanova M, Vodickova L, Vaclavikova R, Smerhovsky Z, Stetina R, Hlavac P, et al. DNA damage, DNA repair rates and mRNA expression levels of cell cycle genes (TP53, p21(CDKN1A), BCL2 and BAX) with respect to occupational exposure to styrene. Carcinogenesis 2011;32:74-9.
46. Venkatachalam R, Ligtenberg MJ, Hoogerbrugge N, de Bruijn DR, Kuiper RP, Geurts van Kessel A. The epigenetics of (hereditary) colorectal cancer. Cancer Genet Cytogenet 2010;203:1-6.
47. Rand K, Qu W, Ho T, Clark SJ, Molloy P. Conversion-specific detection of DNA methylation using real-time polymerase chain reaction (Con-Light-MSP) to avoid false positives. Methods 2002;27:114-20. (Pubitemid 34757121)
48. Hussain Askree S, Hjelm LN, Ali Pervaiz M, Adam M, Bean LJ, Hedge M, et al. Allelic dropout can cause false-positive results for Prader-Willi and Angelman syndrome testing. J Mol Diagn 2011;13:108-12.
49. Kristensen LS, Hansen LL. PCR-based methods for detecting single-locus DNA methylation biomarkers in cancer diagnostics, prognostics, and response to treatment. Clin Chem 2009;55:1471-83.